HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hiroshi Doi Selected Research

Cisplatin (Platino)

1/2021Irinotecan and Gemcitabine as Second-Line Treatment in Patients with Malignant Pleural Mesothelioma following Platinum plus Pemetrexed Chemotherapy: A Retrospective Study.
1/2017First-line chemotherapy with pemetrexed plus cisplatin for malignant peritoneal mesothelioma.
12/2016Radiotherapy in late elderly (aged 75 or older) patients with paranasal sinus carcinoma: a single institution experience.
5/2016SUVmax on FDG-PET is a predictor of prognosis in patients with maxillary sinus cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hiroshi Doi Research Topics

Disease

34Neoplasms (Cancer)
12/2023 - 09/2012
14Rectal Neoplasms (Rectal Cancer)
11/2022 - 11/2013
11Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 04/2008
9Prostatic Neoplasms (Prostate Cancer)
10/2023 - 08/2012
8Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
12/2023 - 04/2011
7Neoplasm Metastasis (Metastasis)
09/2022 - 03/2016
7Malignant Mesothelioma
01/2021 - 08/2016
7Huntington Disease (Huntington's Disease)
10/2016 - 02/2004
5Head and Neck Neoplasms (Head and Neck Cancer)
01/2023 - 03/2015
5Lung Neoplasms (Lung Cancer)
01/2023 - 08/2019
5Atherosclerosis
11/2021 - 01/2012
5Myocardial Infarction
06/2017 - 05/2009
4Disease Progression
12/2023 - 01/2021
4Squamous Cell Carcinoma of Head and Neck
11/2023 - 08/2018
4Ataxia (Dyssynergia)
01/2023 - 10/2019
4Multiple Sclerosis
11/2022 - 02/2018
4Carcinoma (Carcinomatosis)
01/2021 - 03/2015
4Mesothelioma
12/2019 - 01/2017
4Inflammation (Inflammations)
01/2019 - 03/2002
3Squamous Cell Carcinoma (Epidermoid Carcinoma)
04/2024 - 08/2018
3Pharyngeal Neoplasms
01/2024 - 05/2020
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
09/2022 - 01/2019
3Hemorrhage
04/2022 - 01/2016
3Spinocerebellar Ataxias (Spinocerebellar Ataxia)
01/2022 - 10/2019
3Autoimmune Diseases (Autoimmune Disease)
11/2021 - 10/2018
3Oropharyngeal Neoplasms
10/2021 - 01/2018
3Breast Neoplasms (Breast Cancer)
05/2020 - 03/2016
3Proctitis
08/2018 - 07/2011
3Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
10/2016 - 04/2011
3Cysts
02/2013 - 06/2004
3Hypoxia (Hypoxemia)
02/2006 - 05/2004
2Osteoporosis
01/2023 - 01/2021
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2023 - 10/2018
2Ischemic Stroke
01/2023 - 10/2021
2Radiation Pneumonitis
12/2022 - 11/2021
2Neuroinflammatory Diseases
11/2022 - 02/2018
2COVID-19
06/2022 - 01/2021
2Rheumatoid Arthritis
11/2021 - 01/2020
2Hypothyroidism
11/2021 - 05/2015
2Stroke (Strokes)
10/2021 - 01/2021
2Thrombosis (Thrombus)
01/2021 - 05/2009
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 01/2018
2Myoclonic Epilepsies (Myoclonic Encephalopathy)
01/2021 - 10/2019
2Esophageal Squamous Cell Carcinoma
01/2021 - 10/2019
2Hematoma
08/2020 - 01/2019
2Muscular Diseases (Myopathy)
01/2020 - 01/2013
2AIDS-Related Complex (ARC)
03/2019 - 09/2012
2Brain Neoplasms (Brain Tumor)
03/2019 - 01/2019
2Neuromyelitis Optica (Devic's Disease)
10/2018 - 12/2010
2Stomatitis
08/2018 - 03/2015
2Residual Neoplasm
01/2018 - 01/2017
2Atrophy
01/2018 - 01/2013
2Liver Diseases (Liver Disease)
07/2017 - 06/2016
2Hypertension (High Blood Pressure)
06/2017 - 06/2017
2Body Weight (Weight, Body)
05/2017 - 10/2016
2ST Elevation Myocardial Infarction
10/2016 - 09/2015

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2004
8polyglutamineIBA
01/2022 - 02/2004
5Biomarkers (Surrogate Marker)IBA
11/2021 - 05/2016
5AntibodiesIBA
11/2021 - 04/2016
4Messenger RNA (mRNA)IBA
06/2022 - 02/2006
4Cisplatin (Platino)FDA LinkGeneric
01/2021 - 05/2016
4Irinotecan (Camptosar)FDA LinkGeneric
01/2021 - 09/2015
4Retinaldehyde (Retinal)IBA
04/2016 - 07/2010
3EnzymesIBA
08/2023 - 11/2012
3LipidsIBA
04/2022 - 11/2012
3DNA-Binding Proteins (DNA Binding Protein)IBA
01/2022 - 04/2011
3CytokinesIBA
11/2021 - 04/2005
3Pemetrexed (MTA)FDA Link
01/2021 - 01/2017
3polaprezinc (Z 103)IBA
08/2018 - 07/2011
3IronIBA
12/2017 - 03/2010
3RNA (Ribonucleic Acid)IBA
10/2016 - 02/2006
3Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2006 - 05/2004
2Nogo Receptor 1IBA
12/2023 - 02/2018
2Ataxin-2IBA
12/2023 - 01/2022
2Sphingosine-1-Phosphate ReceptorsIBA
11/2022 - 01/2019
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2021 - 03/2019
2AnticoagulantsIBA
10/2021 - 08/2020
2PlatinumIBA
01/2021 - 01/2017
2Dimethyl FumarateIBA
01/2021 - 01/2019
2RNA Polymerase IIIIBA
01/2021 - 11/2011
2Collagen Type IV (Type IV Collagen)IBA
01/2021 - 01/2012
2GonadotropinsIBA
01/2021 - 02/2011
2Myelin-Oligodendrocyte GlycoproteinIBA
01/2021 - 04/2016
2Immunoglobulin G (IgG)IBA
01/2020 - 01/2020
2Adrenal Cortex Hormones (Corticosteroids)IBA
10/2018 - 01/2013
2MethylprednisoloneFDA LinkGeneric
10/2018 - 12/2010
2Protein Isoforms (Isoforms)IBA
06/2017 - 06/2017
2SaltsIBA
06/2017 - 06/2017
2Drinking WaterIBA
05/2017 - 10/2016
2Anti-Bacterial Agents (Antibiotics)IBA
11/2016 - 03/2002

Therapy/Procedure

46Radiotherapy
04/2024 - 09/2012
18Chemoradiotherapy
01/2024 - 12/2014
16Therapeutics
01/2023 - 08/2012
15Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated)
10/2023 - 09/2012
8Drug Therapy (Chemotherapy)
11/2022 - 05/2016
8Stents
07/2017 - 03/2009
3Re-Irradiation
12/2023 - 08/2018
2Segmental Mastectomy (Lumpectomy)
05/2020 - 03/2016
2Neoadjuvant Therapy
12/2019 - 09/2015